Detalhe da pesquisa
1.
The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.
Cardiovasc Diabetol
; 23(1): 13, 2024 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184612
2.
Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.
BMJ Open
; 12(8): e054100, 2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953245